300158 振東製藥
按盤價 
5.420 -0.180 (-3.214%)
5.420 -0.180 (-3.214%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.031 | -8.545 | -29.934 | -0.843 | -0.769 |
| 總資產報酬率 ROA (%) | -0.023 | -6.269 | -23.803 | -0.691 | -0.616 |
| 投入資產回報率 ROIC (%) | -0.029 | -8.092 | -28.856 | -0.807 | -0.728 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.725 | 50.057 | 47.490 | 50.375 | 49.314 |
| 營業利潤率 (%) | 0.608 | -9.520 | -24.055 | -0.827 | -0.159 |
| 息稅前利潤/營業總收入 (%) | 0.643 | -9.925 | -44.301 | -1.303 | 0.126 |
| 淨利潤/營業總收入 (%) | -0.183 | -10.890 | -44.863 | -1.320 | -1.529 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -298.310 | 117.454 | 31.235 | 401.713 | 3,667.027 |
| 價值變動淨收益/利潤總額(%) | 21.736 | -4.455 | 7.412 | -119.491 | -1,250.833 |
| 營業外收支淨額/利潤總額(%) | -33.871 | 4.569 | 45.651 | 20.453 | -12.118 | 償債能力分析 |
| 流動比率 (X) | 2.319 | 2.101 | 2.562 | 4.864 | 4.038 |
| 速動比率 (X) | 1.711 | 1.589 | 1.944 | 3.560 | 3.150 |
| 資產負債率 (%) | 26.040 | 28.398 | 26.541 | 16.769 | 20.266 |
| 帶息債務/全部投入資本 (%) | 7.126 | 5.669 | 2.084 | 1.211 | 2.893 |
| 股東權益/帶息債務 (%) | 1,287.247 | 1,643.078 | 4,613.866 | 7,972.653 | 3,282.543 |
| 股東權益/負債合計 (%) | 287.425 | 255.144 | 279.601 | 499.702 | 395.756 |
| 利息保障倍數 (X) | 3.409 | -194.958 | 1,087.764 | 4.940 | 0.471 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 105.154 | 77.517 | 69.336 | 66.030 | 76.499 |
| 存貨周轉天數 (天) | 195.355 | 184.655 | 227.454 | 227.064 | 191.597 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
